Halfdanarson, T. R., Solnes, L. B., Mancini, B. R., Sibley, G., Anthony, L. B., Liao, C., Starr, J. S., Balaraman, S., Prasad, V., Baratto, L., Hanna, A., Yang, W., Keefe, S. M., Puhlmann, M., Wahl, R. L. (2025). [
            <sup>212</sup>
            Pb]VMT-α-NET therapy in somatostatin receptor 2 (SSTR2) expressing neuroendocrine tumors (NETs): Dose-limiting toxicity (DLT) observation participants after 1 year follow-up and preliminary report for expansion participants.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3005